Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dysregulation in CD39/CD73 Axis May Trigger the Upsurge of the Immune Suppressive Agent Adenosine in OSA Patients.
Díaz-García E, García-Sánchez A, Alfaro E, López-Fernández C, Mañas E, Casitas R, Vega S, Cano-Pumarega I, García-Río F, Cubillos-Zapata C. Díaz-García E, et al. Among authors: garcia sanchez a. Arch Bronconeumol. 2024 Apr;60(4):207-214. doi: 10.1016/j.arbres.2024.02.013. Epub 2024 Feb 27. Arch Bronconeumol. 2024. PMID: 38485582 English, Spanish.
Macular vessel density in the superficial plexus is not a proxy of cerebrovascular damage in non-demented individuals: data from the NORFACE cohort.
García-Sánchez A, Sotolongo-Grau O, Tartari JP, Sanabria Á, Esteban-De Antonio E, Pérez-Cordón A, Alegret M, Pytel V, Martínez J, Aguilera N, de Rojas I, Cano A, García-González P, Puerta R, Olivé C, Capdevila M, García-Gutiérrez F, Vivas A, Gómez-Chiari M, Giménez J, Tejero MÁ, Castilla-Martí M, Castilla-Martí L, Tárraga L, Valero S, Ruiz A, Boada M, Marquié M; FACEHBI study group; BIOFACE study group. García-Sánchez A, et al. Alzheimers Res Ther. 2024 Feb 20;16(1):42. doi: 10.1186/s13195-024-01408-9. Alzheimers Res Ther. 2024. PMID: 38378643 Free PMC article.
Genome-wide association study and polygenic risk scores of retinal thickness across the cognitive continuum: data from the NORFACE cohort.
Sáez ME, García-Sánchez A, de Rojas I, Alarcón-Martín E, Martínez J, Cano A, García-González P, Puerta R, Olivé C, Capdevila M, García-Gutiérrez F, Castilla-Martí M, Castilla-Martí L, Espinosa A, Alegret M, Ricciardi M, Pytel V, Valero S, Tárraga L, Boada M, Ruiz A, Marquié M. Sáez ME, et al. Among authors: garcia sanchez a. Alzheimers Res Ther. 2024 Feb 16;16(1):38. doi: 10.1186/s13195-024-01398-8. Alzheimers Res Ther. 2024. PMID: 38365752 Free PMC article.
Unveiling the sound of the cognitive status: Machine Learning-based speech analysis in the Alzheimer's disease spectrum.
García-Gutiérrez F, Alegret M, Marquié M, Muñoz N, Ortega G, Cano A, De Rojas I, García-González P, Olivé C, Puerta R, García-Sanchez A, Capdevila-Bayo M, Montrreal L, Pytel V, Rosende-Roca M, Zaldua C, Gabirondo P, Tárraga L, Ruiz A, Boada M, Valero S. García-Gutiérrez F, et al. Among authors: garcia sanchez a. Alzheimers Res Ther. 2024 Feb 2;16(1):26. doi: 10.1186/s13195-024-01394-y. Alzheimers Res Ther. 2024. PMID: 38308366 Free PMC article.
The Inflammatory and Oxidative Status of Newly Diagnosed Class III and Class IV Lupus Nephritis, with Six-Month Follow-Up.
Cerrillos-Gutiérrez JI, Medina-Pérez M, Andrade-Sierra J, De Alba-Razo A, Pacheco-Moisés FP, Cardona-Muñoz EG, Campos-Pérez W, Martínez-López E, Sánchez-Lozano DI, García-Sánchez A, Campos-Bayardo TI, Miranda-Díaz AG. Cerrillos-Gutiérrez JI, et al. Among authors: garcia sanchez a. Antioxidants (Basel). 2023 Dec 1;12(12):2065. doi: 10.3390/antiox12122065. Antioxidants (Basel). 2023. PMID: 38136185 Free PMC article.
[Modified CAMBRA questionnaire as a method for population-based caries risk screening without exploratory methods: a cross-sectional observational pilot study].
Mateos-Moreno MV, Salgado-Peralvo ÁO, Kewalramani N, García-Sánchez Á, Garcillán-Izquierdo MR, Mateos-Moreno B, Dorado-Jara L, Berzal-Pérez M, Vivas-Mefle CA. Mateos-Moreno MV, et al. Among authors: garcia sanchez a. Rev Esp Salud Publica. 2023 Dec 20;97:e202312112. Rev Esp Salud Publica. 2023. PMID: 38126529 Spanish.
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.
Llovet JM, Kudo M, Merle P, Meyer T, Qin S, Ikeda M, Xu R, Edeline J, Ryoo BY, Ren Z, Masi G, Kwiatkowski M, Lim HY, Kim JH, Breder V, Kumada H, Cheng AL, Galle PR, Kaneko S, Wang A, Mody K, Dutcus C, Dubrovsky L, Siegel AB, Finn RS; LEAP-002 Investigators. Llovet JM, et al. Lancet Oncol. 2023 Dec;24(12):1399-1410. doi: 10.1016/S1470-2045(23)00469-2. Lancet Oncol. 2023. PMID: 38039993 Clinical Trial.
297 results